Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Placebo-controlled trials in schizophrenia].

Yuval Melamed1, Michael Davidson, Avi Bleich

  • 1Lev-Hasharon Mental Health Center, Pardessiya.

Harefuah
|April 7, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Severe Hypertriglyceridemia Managed in a Pregnant Patient Using Nonstatin Therapies.

JACC. Case reports·2026
Same author

Negative symptoms in schizophrenia: Methodological challenges and emerging solutions for outcome measurement.

Neuroscience applied·2026
Same author

Xanomeline/trospium and suicide-related events in schizophrenia: An early pharmacovigilance analysis.

Schizophrenia research·2026
Same author

Moderate to severe negative symptoms predict low risk of symptoms worsening in schizophrenia patients in CATIE.

Schizophrenia research·2026
Same author

Modeling Negative Symptom Domain Neurobiology: Protocol for an Observational, Transdiagnostic, Translational Study.

JMIR research protocols·2026
Same author

Quality of life in early-phase schizophrenia patients starting treatment with long-acting injectable vs. oral antipsychotic drugs: Data from the European Long-acting Antipsychotics in Schizophrenia Trial (EULAST).

European psychiatry : the journal of the Association of European Psychiatrists·2026
Same journal

[Tennis Elbow Among Players].

Harefuah·2026
Same journal

[Internal Medicine - My Mission].

Harefuah·2026
Same journal

[Treatment of Morbid Obesity in Israel: GLP-1 Agonists Versus Bariatric Surgery - Clinical and Economic Aspects].

Harefuah·2026
Same journal

[Baby steps: Post-operative Treatment Recommendations for Pediatric Tracheostomy in Israel].

Harefuah·2026
Same journal

[Mastoiditis Caused by Fusobacterium Necrophorum: an Unusual Pathogen in a Well-Known Disease].

Harefuah·2026
Same journal

[Cochlear Implantation in Single-Sided Deafness - Six Years of Follow-Up from Diagnosis and Consistent Use, Through Dedicated and Creative Auditory Learning, to the Development of Bilateral Central Processing Abilities].

Harefuah·2026
See all related articles

Placebo-controlled trials are essential in psychiatric research but pose ethical challenges, especially for patients with mental illness. Strict guidelines are proposed to ensure patient safety and ethical conduct in these crucial clinical trials.

Area of Science:

  • Psychiatric research
  • Clinical pharmacology
  • Medical ethics

Context:

  • Clinical trials involving human subjects present ethical and medico-legal challenges.
  • Mentally ill patients raise complex issues regarding informed consent and potential exposure to ineffective treatments or placebo.
  • The development of new psychiatric medications necessitates careful consideration of trial design.

Purpose:

  • To develop a position paper on placebo-controlled clinical trials in schizophrenia patients.
  • To address the ethical and clinical dilemmas associated with placebo use in psychiatric research.
  • To establish guidelines for conducting ethical and scientifically sound clinical trials in psychiatry.

Summary:

  • Placebo-controlled trials are vital for advancing psychiatric medicine, despite ethical complexities concerning mentally ill individuals.

Related Experiment Videos

  • The use of placebo in psychiatric trials is not inherently unethical but requires stringent oversight and justification.
  • Proposed criteria for approving placebo-controlled trials include scientific and clinical justification, informed consent, patient safety, and robust supervision.

    • Impact:

    • Provides a framework for ethical conduct in psychiatric clinical trials.
    • Facilitates the development of new, effective treatments for mental illnesses.
    • Ensures patient welfare while advancing medical knowledge in psychiatry.